08 January 2021

The U.S. Food and Drug Administration (FDA) continued to take action in the ongoing response to the COVID-19 pandemic:

The FDA alerted clinical laboratory staff and health care providers that genetic variants of SARS-CoV-2 may lead to false negative results with molecular tests for SARS-CoV-2.··(중략)

원문 바로보기 https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-january-8-2021